These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16246051)

  • 1. The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.
    Walsh DM; Klyubin I; Shankar GM; Townsend M; Fadeeva JV; Betts V; Podlisny MB; Cleary JP; Ashe KH; Rowan MJ; Selkoe DJ
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1087-90. PubMed ID: 16246051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
    Rowan MJ; Klyubin I; Wang Q; Anwyl R
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.
    Klyubin I; Walsh DM; Lemere CA; Cullen WK; Shankar GM; Betts V; Spooner ET; Jiang L; Anwyl R; Selkoe DJ; Rowan MJ
    Nat Med; 2005 May; 11(5):556-61. PubMed ID: 15834427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
    Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
    Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.
    Rowan MJ; Klyubin I; Wang Q; Hu NW; Anwyl R
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1219-23. PubMed ID: 17956317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic plasticity in animal models of early Alzheimer's disease.
    Rowan MJ; Klyubin I; Cullen WK; Anwyl R
    Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):821-8. PubMed ID: 12740129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPYFDa neutralizes amyloid-beta-induced memory impairment and toxicity.
    Granic I; Masman MF; Kees Mulder C; Nijholt IM; Naude PJ; de Haan A; Borbély E; Penke B; Luiten PG; Eisel UL
    J Alzheimers Dis; 2010; 19(3):991-1005. PubMed ID: 20157254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity.
    Rowan MJ; Klyubin I; Wang Q; Anwyl R
    Exp Gerontol; 2004; 39(11-12):1661-7. PubMed ID: 15582282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.
    Hu NW; Smith IM; Walsh DM; Rowan MJ
    Brain; 2008 Sep; 131(Pt 9):2414-24. PubMed ID: 18678563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PP1 inhibition by Abeta peptide as a potential pathological mechanism in Alzheimer's disease.
    Vintém AP; Henriques AG; da Cruz E Silva OA; da Cruz E Silva EF
    Neurotoxicol Teratol; 2009; 31(2):85-8. PubMed ID: 19028567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Abeta interactions using ProteinChip technology.
    Giannakis E; Hung LW; Camacaro KP; Smith DP; Barnham KJ; Wade JD
    Methods Mol Biol; 2008; 494():71-86. PubMed ID: 18726569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RS-0406 arrests amyloid-beta oligomer-induced behavioural deterioration in vivo.
    O'Hare E; Scopes DI; Treherne JM; Norwood K; Spanswick D; Kim EM
    Behav Brain Res; 2010 Jun; 210(1):32-7. PubMed ID: 20138088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation.
    Lee CC; Kuo YM; Huang CC; Hsu KS
    Neurobiol Aging; 2009 Mar; 30(3):377-87. PubMed ID: 17692997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The essential role of lipids in Alzheimer's disease.
    Florent-Béchard S; Desbène C; Garcia P; Allouche A; Youssef I; Escanyé MC; Koziel V; Hanse M; Malaplate-Armand C; Stenger C; Kriem B; Yen-Potin FT; Olivier JL; Pillot T; Oster T
    Biochimie; 2009 Jun; 91(6):804-9. PubMed ID: 19303044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
    Chackerian B; Rangel M; Hunter Z; Peabody DS
    Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.